Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy.
Shah S, Nelson CP, Gaunt TR, van der Harst P, Barnes T, Braund PS, Lawlor DA, Casas JP, Padmanabhan S, Drenos F, Kivimaki M, Talmud PJ, Humphries SE, Whittaker J, Morris RW, Whincup PH, Dominiczak A, Munroe PB, Johnson T, Goodall AH, Cambien F, Diemert P, Hengstenberg C, Ouwehand WH, Felix JF, Glazer NL, Tomaszewski M, Burton PR, Tobin MD, van Veldhuisen DJ, de Boer RA, Navis G, van Gilst WH, Mayosi BM, Thompson JR, Kumari M, MacFarlane PW, Day IN, Hingorani AD, Samani NJ. Shah S, et al. Among authors: van gilst wh, van der harst p, van veldhuisen dj. Circ Cardiovasc Genet. 2011 Dec;4(6):626-35. doi: 10.1161/CIRCGENETICS.111.960203. Epub 2011 Sep 30. Circ Cardiovasc Genet. 2011. PMID: 21965548 Free PMC article.
Effect of isradipine and nifedipine on diastolic function in patients with left ventricular dysfunction due to coronary artery disease: a randomized, double-blind, nuclear, stethoscope study.
Wout van den Toren E, de Vries RJ, Portegies MC, Blanksma PK, van Gilst WH, Hillege HJ, van Veldhuisen DJ, Lie KI. Wout van den Toren E, et al. Among authors: van gilst wh, van veldhuisen dj. J Cardiovasc Pharmacol. 1994 Jun;23(6):952-8. doi: 10.1097/00005344-199406000-00014. J Cardiovasc Pharmacol. 1994. PMID: 7523788 Clinical Trial.
Current insights and new treatment options in heart failure.
van Veldhuisen DJ, van Gilst WH, Francis GS. van Veldhuisen DJ, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 1998;32 Suppl 1:v-vi. doi: 10.1097/00005344-199800003-00001. J Cardiovasc Pharmacol. 1998. PMID: 9731688 No abstract available.
Vasopeptidase inhibition in heart failure.
van Veldhuisen DJ, van Gilst WH. van Veldhuisen DJ, et al. Among authors: van gilst wh. Lancet. 2000 Oct 28;356(9240):1526. doi: 10.1016/S0140-6736(05)73277-3. Lancet. 2000. PMID: 11081561 No abstract available.
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer RA, van Geel PP, Pinto YM, Suurmeijer AJ, Crijns HJ, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: van gilst wh, van geel pp, van veldhuisen dj. J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017. J Cardiovasc Pharmacol. 2002. PMID: 11904535
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Hillege HL, et al. Among authors: van gilst wh, van veldhuisen dj. Circulation. 2002 Oct 1;106(14):1777-82. doi: 10.1161/01.cir.0000031732.78052.81. Circulation. 2002. PMID: 12356629
The pharmacological management of heart failure: too many treatments?
van Veldhuisen DJ, van Gilst WH. van Veldhuisen DJ, et al. Among authors: van gilst wh. Eur J Heart Fail. 2003 Jan;5(1):5-8. doi: 10.1016/s1388-9842(02)00159-9. Eur J Heart Fail. 2003. PMID: 12559208 Free article. Review. No abstract available.
Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.
de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Res. 2003 Feb;57(2):434-42. doi: 10.1016/s0008-6363(02)00704-6. Cardiovasc Res. 2003. PMID: 12566116
513 results